| Page 1196 | Kisaco Research
 

Alex Armesilla

Director – Cell Engineering
Resolution Therapeutics

Alex Armesilla

Director – Cell Engineering
Resolution Therapeutics

Alex Armesilla

Director – Cell Engineering
Resolution Therapeutics

ESG Testimonial 5

Presentations were excellent providing the right balance between practical examples and overall policy

ESG Testimonial 4

The conference was rich in content and attendees, representing industry professionals and service providers. The intimacy of the conference allowed for thoughtful and intriguing perspectives, impactful dialogue, and valuable connections.

 

Anthony Conway

Director
Stem Cell Research, Novo Nordisk

Anthony Conway

Director
Stem Cell Research, Novo Nordisk

Anthony Conway

Director
Stem Cell Research, Novo Nordisk

ESG Testimonial 3

The ESG Risk Management Summit 2022 presented thought-provoking speakers with practical insights (beyond just theory), panel discussions were well-rounded with salient topics and it was a great opportunity to meet with others in the industry and share best practices, lessons learned and pathways to move forward (and stay above water) in the ever-evolving ESG landscape.

 

Andrew Voysey

Head of Impact and Carbon
Soil Capital

Andrew is Head of Impact and Carbon at Soil Capital, the regenerative agronomy firm that launched Europe’s first certified, multinational carbon payment programme for farmers in 2020.

Andrew led the development of this programme, called Soil Capital Carbon, which has now enrolled more than 500 British, French and Belgian farmers. The programme has recently paid out nearly 1 million Euros to farmers for their first year's performance, with the majority of those payments coming from food and agri businesses within the supply chain.

Andrew Voysey

Head of Impact and Carbon
Soil Capital

Andrew Voysey

Head of Impact and Carbon
Soil Capital

Andrew is Head of Impact and Carbon at Soil Capital, the regenerative agronomy firm that launched Europe’s first certified, multinational carbon payment programme for farmers in 2020.

Andrew led the development of this programme, called Soil Capital Carbon, which has now enrolled more than 500 British, French and Belgian farmers. The programme has recently paid out nearly 1 million Euros to farmers for their first year's performance, with the majority of those payments coming from food and agri businesses within the supply chain.

Soil Capital began life as an independent agronomy firm specialised in helping farmers improve farm profitability through transitions to regenerative agriculture. This activity continues through a separate entity, Soil Capital Farming, now with a track record across more than 200,000 hectares and 21 countries. Prior to Soil Capital, Andrew spent a decade building the sustainable finance practice at the University of Cambridge Institute for Sustainability Leadership. During this time, he led several industry collaborations between the finance and food and farming sectors and was an advisor on climate change at the Bank of England.

 

Kimberly Schluns

Senior Director
Research, Kite Pharma

Kimberly Schluns

Senior Director
Research, Kite Pharma

Kimberly Schluns

Senior Director
Research, Kite Pharma
 

David Vereide

iPSC Lead
Umoja Biopharma

David Vereide

iPSC Lead
Umoja Biopharma

David Vereide

iPSC Lead
Umoja Biopharma

ESG Testimonial 2

I was sent to this event to learn how our organization can begin the journey that is ESG. Without knowing what to expect, I came away with a wide array of knowledge, best practices, and practical applications that will help my organization achieve ESG goals. Every delegate, speaker, and panelist I met were well informed and shared their knowledge and experience with me. And I met some colleagues that I can count on to share ESG information and best practices for the future. We are all in this together and that was a central theme of this program.

 

Teisha Rowland

iPSC Lead
Umoja Biopharma

Teisha Rowland

iPSC Lead
Umoja Biopharma

Teisha Rowland

iPSC Lead
Umoja Biopharma